OHE at ISPOR Europe: Presentations

The OHE gave the following presentations at ISPOR 17th Annual European Congress in Amsterdam, The Netherlands.

What Value Do We Place on a Cure? Value Demonstration Challenges Associated with Innovator and Regenerative Therapies in the EU, North America, and Asia.

Moderator: Eric C Faulkner (University of North Carolina, Chapel Hill) Panelists: Adrian Towse (OHE), Don Husereau, University of Ottawa and UMIT, Joshua J. Carlson (VeriTech Corporation).

Regenerative medicine akt_nov14 from Office of Health Economics

An Introduction to Multi-criteria Decision Analysis in Health Care Decision Making – Emerging Good Practices.

Chair: Maarten J IJzerman, University of Twente and MIRA Institute for Biomedical Technology & Technical Medicine.; Speakers: Nancy Devlin (OHE), Praveen Thokala (University of Sheffield) and Kevin Marsh (Evida).

MCDA devlin nov14 from Office of Health Economics

Earlier Access to Innovation – Is It worth It?

Moderator: Adrian Towse (OHE), with.Hans-Georg Eichler (EMA), Richard Bergstrom (EFPIA), Carole Longson (NICE), and Alric Reuther (IQWiG).

Adaptive pathways intro_ispor_second_plenary_nov14 from Office of Health Economics

Value-based Assessment for NICE: How to Do the Calculations.

Discussion Leaders: Jeanette Kusel (Costello Medical Consulting Ltd), Meindert Boysen (NICE), Koonal K. Shah (OHE) and Anthony J Hatswell (BresMed).

Ispor workshop value-based_assess_nice_kks_nov2014 from Office of Health Economics

News & Insights

Latest Research & Publications

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

Are Recommendations for HTA of Gene Therapies Being Achieved?

The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

Delivering the Triple Win: A Value-Based Approach to Pricing

All Publications

OHE at ISPOR Europe: Presentations

Related News

Assessing the Productivity Value of Vaccines in Health Technology Assessment: Worth a Shot?

Are Discount Rates Used in UK Vaccine Economic Evaluations Jeopardising Investment in Immunisation Programmes?

NICE ‘Optimised’ Recommendations: What Do They Mean for Patient Access?

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.